The top 3 stories from today's briefing, narrated as a short audio episode.
Sign up free to listen. The briefing notes below are free to read.
Briefing Notes
Capital Markets
US law firms displace original Magic Circle in London's 2026 elite ranking as NQ pay gap widens to £39,000
A £39,000 NQ pay gap is forcing the original Magic Circle to compete on deal quality, not just brand — talent retention is now the existential issue.
Banking & Finance
Russian court refuses to recognise two LCIA arbitration awards against RUSAL on public order grounds, in a significant enforcement setback for cross-border creditors
Russian courts blocking LCIA awards against RUSAL means creditors must hunt assets jurisdiction by jurisdiction — enforcement has become a multi-front exercise.
Disputes
Faruqi & Faruqi Files Securities Class Action Against SES AI Corporation as Lead Plaintiff Deadline Falls on 26 June 2026
Securities class actions turn on the gap between what was said and what was known.
Energy & Tech
UK prime minister reported to face possible resignation as early as Monday, adding political uncertainty to energy and infrastructure policy pipeline
A UK leadership change mid-energy transition puts CfD schedules and nuclear financing timelines at risk — project finance due diligence must now price political continuity.
Regulation
Securities class action filed against Via Transportation over allegedly misleading IPO documents as shares fall nearly 70% from offer price
A 70% post-IPO share collapse and a class action over omitted revenue data is the canonical reason prospectus verification exists.
International
Congo Ebola Outbreak Reaches 956 Confirmed Cases and 247 Deaths as Cross-Border Health Emergency Deepens
An outbreak of this scale activates legal obligations long before a WHO emergency declaration.
AI & Law
LegalTechTalk 2026 panel asks how law firms remain relevant when AI is universal, as legal design and engineering emerge as the profession's next differentiation layer
When every firm has the same AI tools, legal design and engineering become the only remaining basis for premium advisory differentiation.
M&A
Sun Pharma to acquire Indian pharma company Innovcare Lifesciences for $28.7m
India's generics giants are building domestic branded portfolios through sub-$50m bolt-ons — steady M&A deal flow at mid-market volume.